Gold fell to 4,032 USD per ounce on Thursday, marking its second consecutive day of decline. Pressure on the market intensified amid fears that a new escalation of conflict in the Middle East could disrupt Read more…
Markets Oil prices yesterday peaked at north of $80 in the wake of renewed attacks between the US and Iran. The recovery from +/- $70 levels seen earlier this month isn’t markets betting on full-blown Read more…
Tesla’s (TSLA) fresh bull case lands at a strange moment for the stock. Investors were anxiously waiting for a demand reset after concerns of some major EV competition, sluggish margins, and lackluster growth. However, in Read more…
Hello fellow traders. In this technical article we’re going to take a quick look at the Elliott Wave charts of Silver Commodity XAGUSD . As our members know, both Silver and Gold are showing incomplete Read more…
Hello traders. In this technical article we’re going to look at the Elliott Wave charts of GOLD commodity published in members area of the website. As our members know, GOLD is shoing incomplete bearish sequences in Read more…
TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. Why we love this deal Now that it’s summer, you’re probably Read more…
Gold and silver have lost the momentum generated by their recent rebounds, but sellers have yet to secure the decisive breakdown they are looking for. Gold’s recovery stalled at 4202.87, while silver turned lower after Read more…
Key Highlights Ethereum failed to clear the $1,825 resistance and trimmed gains. A bullish trend line is forming with support at $1,665 on the 4-hour chart of ETH/USD. Bitcoin price also struggled above $64,000 and Read more…
China’s consumer inflation eased further in June, highlighting subdued domestic price pressures even as producer inflation climbed to its highest level in nearly three years. Consumer prices fell -0.3% mom, steeper than the expected -0.2% Read more…
Eli Lilly (LLY) keeps setting records, and Wall Street’s rating of its stock keeps increasing as well. On Tuesday, one of JPMorgan’s most closely watched healthcare stock analysts, Chris Schott, who frequently covers Pfizer Inc. Read more…